Pharma Journalist -

Boehringer Ingelheim has acquired a minority stake in SoundTalks NV, a Belgian company. SoundTalks NV has developed a digital monitoring tool that seeks to improve the healthcare of…
Read More...

Catalent and Paragon Bioservices announced they have entered into a definitive agreement under which Catalent will acquire Paragon for $1.2 billion. “Paragon’s unparalleled expertise…
Read More...

Dr. Reddy’s Laboratories Ltd. announced that it has entered into a definitive agreement to acquire a portfolio of 42 approved, non-marketed Abbreviated New Drug Applications (ANDAs) in…
Read More...

Bristol-Myers Squibb Company announced that its shareholders voted to approve the issuance of shares of Bristol-Myers Squibb common stock in connection with the Company’s pending merger…
Read More...

AstraZeneca and MSD Inc., Kenilworth, N.J., US (MSD: known as Merck & Co., Inc. inside the US and Canada) announced the European Commission has approved Lynparza (olaparib) as a…
Read More...

Sanofi and Alnylam have agreed to conclude the research and option phase of the companies’ 2014 RNAi therapeutics alliance in rare genetic diseases. The material collaboration terms for…
Read More...

Exploring Novel Technologies and Bolstering Lyophilisation Strategies for Freeze Drying Optimisation An understanding of the current freeze drying methods, new technologies,…
Read More...

Developing a Human Factors Validation Plan with Consideration for the Digital Health Marketplace This workshop will provide an overview of human factors validation strategies that…
Read More...

Evotec SE and Indivumed GmbH announced that they have entered into a research collaboration to discover and develop first-in-class therapeutics for the treatment of colorectal cancer…
Read More...

Moleculin Biotech announced it has entered into an agreement with Emory University to conduct a Phase 1 clinical trial of WP1066 in children with recurrent or refractory malignant brain…
Read More...